CDCA8 was reported to stimulate tumor development of hepatocellular carcinoma (HCC) via the potentiation of cell cycle progression factors, such as cyclins, Ki 67, and PCNA [30,31]. Here, CDCA8 is linked to hepatocellular carcinoma.